ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC

  • Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J. & Der, C. J. Drugging the undruggable RAS: mission possible? Nat. Rev. Drug Discov. 13, 828–851 (2014).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Continue Reading